Information Provided By: 
Fly News Breaks for December 6, 2016
CVS
Dec 6, 2016 | 07:45 EDT
As previously reported, BofA/Merrill added CVS Health to the US 1 List. Analyst Steven Valiquette said the recent pullback in shares has provided a buying opportunity and believes it is a clear beneficiary from the recent US election results due to benefits from an improved branded drug pricing environment and US corporate tax reform. The analyst rates CVS a Buy with an $89 price target.
News For CVS From the Last 2 Days
There are no results for your query CVS
